News Focus
News Focus
icon url

The Danish Dude

09/17/23 9:32 AM

#631556 RE: Jackxkr #631553

You are in luck. Consider yourself served.

Hope it is but till I see NWBO attached to it is UCLA's



Linda Liau being interviewed for article about combo trial content, while working with ATL-DC at UCLA.







Shall I find Linda Liau presentation slides or something as exhilarating from the world of realities corroborating DCVax-L is indeed ATL-DC in the poly-iclc combo trial?

Or does bias come with a pay cheque?
Bullish
Bullish
icon url

biosectinvestor

09/17/23 8:44 PM

#631713 RE: Jackxkr #631553

Doesn’t matter what you think. It is what it is, DCVax-L. They even footnote both papers on DCVax-L in their reference to methods and previous studies. There is no question. And again, Linda Liau is now in the SAB. It strains credulity to think anything else is going on, also knowing this was funded by the SPORE grant and also again, was and is for DCVax-L, same vaccine.